Morishige K

No ORCID on file · 4 papers in corpus · active 2009-2015

Study types

  • article 1

Condition tags

  • endometriosis 1
article 2015
Exploratory study of pre‐surgical medications with dienogest or leuprorelin in laparoscopic cystectomy of endometrial cysts
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.12701

AIM: The aim of this study was to compare the effects of pre-surgical medication with dienogest or leuprorelin on post-surgical ovarian function. MATERIAL AND METHODS: We conducted an exploratory study in two centers in Japan that comprised…

2015
Magnetic resonance imaging of uterine fibroids: a preliminary investigation into the usefulness of 3D-rendered images for surgical planning.
SpringerPlus ·doi:10.1186/s40064-015-1170-9

PurposeThis study aimed to assess the efficacy of 3D surface-rendered (SR) magnetic resonance (MR) images for surgical planning of uterine fibroids.MethodsTen patients with uterine fibroids underwent 3D volume isotropic turbo spin-echo acqu…

2010
Vascular endothelial growth factor is a promising therapeutic target for the treatment of clear cell carcinoma of the ovary.
Molecular cancer therapeutics ·doi:10.1158/1535-7163.mct-10-0169

This study examines the role of vascular endothelial growth factor (VEGF) as a therapeutic target in clear cell carcinoma (CCC) of the ovary, which has been regarded as a chemoresistant histologic subtype. Immunohistochemical analysis using…

2009
mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovary.
Clinical cancer research : an official journal of the American Association for Cancer Research ·doi:10.1158/1078-0432.ccr-09-0365

PurposeMammalian target of rapamycin (mTOR) plays a central role in cell proliferation and is regarded as a promising target in cancer therapy, including for ovarian cancer. This study aimed to examine the role of mTOR as a therapeutic targ…